Organisation
Laboratory of Tumor Inflammation and Angiogenesis (VIB-KU Leuven)
Division
The Lab of Molecular Oncology and Angiogenesis aims to shed light on the genetic and molecular mechanisms that regulate vessel shape remodeling and endothelial cell fate, with the overall aim of defining alternative therapeutic opportunities to improve anti-cancer therapy, as well as therapeutic angiogenesis for revascularization of ischemic tissues.
Projects
41 - 50 of 69
- Impact of multimodality therapy in esophageal cancer on disease, patient and treatmentFrom1 Sep 2016 → 23 May 2019Funding: Own budget, for example: patrimony, inscription fees, gifts
- Unraveling the role of the PP2A regulatory subunit B55alpha in tumor-infiltrating immune cellsFrom1 Jul 2016 → 11 Feb 2022Funding: FWO Strategic Basic Research Grant, Nonprofit institution or equivalents
- Development of a technology platform for next-generation cytometryFrom1 Jul 2016 → 30 Jun 2020Funding: FWO Large scale research infrastructure
- The impact of hypoxia on inflammation and tumorigenesis in Ulcerative Colitistrus.From1 May 2016 → 30 Apr 2021Funding: FWO research project (including WEAVE projects)
- CRYPTIC TRANSCRIPTS: THE MASKED HEROES WHO BREAK TUMOR IMMUNE TOLERANCE AND FREE THE RESPONSE TO IMMUNE THERAPY.From1 Oct 2015 → 31 Jul 2021Funding: FWO fellowships
- Podoplanin-Expressing Macrophages (PoEMs) Promote Lymphangiogenesis and Lymphoinvasion in Breast CancerFrom18 Aug 2015 → 6 Nov 2019Funding: Own budget, for example: patrimony, inscription fees, gifts
- Exploring the metabolic pathways driving tumor-associated macrophage polarization and their influence on tumor progression.From1 Jan 2015 → 31 Dec 2018Funding: FWO research project (including WEAVE projects)
- Podoplanin: the missing link between breast cancer and lymphatic metastasis?From1 Jan 2015 → 31 Dec 2018Funding: FWO research project (including WEAVE projects)
- Mir-210 at the crossroad of M2 and M1 macrophage polarization: relevance for sepsis and cancer.From1 Jan 2015 → 31 Dec 2017Funding: FWO research grant KAN
- Exploring the metabolic pathways driving tumorassociated macrophage polarization and their influence on tumor progression..From1 Oct 2014 → 30 Sep 2018Funding: FWO fellowships
Publications
1 - 10 of 314
- Evolution of the Experimental Models of Cholangiocarcinoma(2020)
Authors: Chiara Varamo
- Insulin potentiates FcepsilonRI-mediated signaling in mouse bone marrow-derived mast cells(2010)
Authors: Mario di Matteo
Pages: 1039 - 1046 - In vivo antitumoral efficacy of PhAc-ALGP-doxorubicin, an enzyme-activated doxorubicin prodrug, in patient-derived soft tissue sarcoma xenograft models(2017)
Authors: Jasmien Cornillie, Agnieszka Wozniak, Peter Pokreisz, Andrea Casazza, Yemarshet Kelemework Gebreyohannes, Maria Debiec-Rychter, Raf Sciot, Daphne Hompes, Patrick Schöffski
Pages: 1566 - 1575 - microRNAs in ES Cell Differentiation(2012)
Authors: Emanuele Berardi, Lieven Thorrez, Maurilio Sampaolesi
Pages: H931 - H939 - Podoplanin-Expressing Macrophages (PoEMs) Promote Lymphangiogenesis and Lymphoinvasion in Breast Cancer(2019)
Authors: Pawel Jacek Bieniasz-Krzywiec, Max Mazzone
- PRO-INVASIVE TUMOUR-STROMA INTERACTIONS: ROLE OF THE SECRETED OXIDOREDUCTASE CLIC3(2019)
Authors: Juan R Hernandez-Fernaud, Elena Ruengeler, Lisa J Neilson, Shehab Ismail, Iain McNeish, Samuel Atkinson, Sergio Lilla, Alice Santi, Stella M Valenzuela, Karen Blyth, et al.
Pages: 136 - 136 - Hypoxic cancer-associated fibroblasts increase NCBP2-AS2/HIAR to promote endothelial sprouting through enhanced VEGF signaling(2019)
Authors: Shehab Ismail Mohamed, Max Mazzone
- Identification of a chronic non-neurodegenerative microglia activation state in a mouse model of peroxisomal β-oxidation deficiency(2015)
Authors: Simon Verheijden, Lien Beckers, Andrea Casazza, Oleg Butovsky, Max Mazzone, Myriam Baes
Pages: 1606 - 20 - Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment(2014)
Authors: Andrea Casazza, Giusy Di Conza, Mathias Wenes, Veronica Finisguerra, Sofie Deschoemaeker, Max Mazzone
Pages: 1743 - 1754 - Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform(2012)
Authors: Andrea Casazza, Max Mazzone
Pages: 234 - 50